The STriTuVaD Consortium announces the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for TB

The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB).  Please read the press release